|
KIFAP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.930200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.427800E-01 |
| Normal-vs-Stage2 |
5.808800E-01 |
| Normal-vs-Stage3 |
2.303400E-01 |
| Normal-vs-Stage4 |
5.206800E-01 |
| Stage1-vs-Stage2 |
4.267800E-01 |
| Stage1-vs-Stage3 |
3.266400E-01 |
| Stage1-vs-Stage4 |
7.110800E-01 |
| Stage2-vs-Stage3 |
2.091400E-01 |
| Stage2-vs-Stage4 |
3.609200E-01 |
| Stage3-vs-Stage4 |
5.867200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.011800E-01 |
| Normal-vs-AfricanAmerican |
3.161200E-01 |
| Normal-vs-Asian |
8.157000E-01 |
| Caucasian-vs-AfricanAmerican |
4.540800E-01 |
| Caucasian-vs-Asian |
9.308400E-01 |
| AfricanAmerican-vs-Asian |
8.375800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.709800E-02 |
| Normal-vs-Female |
1.673210E-01 |
| Male-vs-Female |
2.395800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.079700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.557800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.763400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.303600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.034590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.352200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.475250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.794400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.052600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.794400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.131220E-01 |
| Normal-vs-Grade 2 |
8.117400E-01 |
| Normal-vs-Grade 3 |
2.034000E-01 |
| Normal-vs-Grade 4 |
6.013700E-02 |
| Grade 1-vs-Grade 2 |
1.997040E-01 |
| Grade 1-vs-Grade 3 |
4.682200E-02 |
| Grade 1-vs-Grade 4 |
5.192400E-02 |
| Grade 2-vs-Grade 3 |
1.428030E-01 |
| Grade 2-vs-Grade 4 |
5.882200E-02 |
| Grade 3-vs-Grade 4 |
4.175600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.458800E-03 |
| Normal-vs-ccB subtype |
3.125000E-03 |
| ccA subtype-vs-ccB subtype |
2.39769999965667E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.178800E-01 |
| Normal-vs-N1 |
3.159000E-01 |
| N0-vs-N1 |
2.936000E-01 |
|
|
